Hospital News and Research

RSS

Race impacts risk of heart disease after gestational diabetes

New research finds that gestational diabetes, or pregnancy-related diabetes, may not raise the risk of heart disease independent of other cardiovascular risk factors except in certain high-risk populations, such as Hispanics. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.

7 Jun 2011

Higher than IOM recommended Vitamin D levels required for optimizing osteoporosis, low BMD therapy

To fully optimize a drug therapy for osteoporosis and low bone mineral density (BMD), patients should maintain vitamin D levels above the limits recently recommended by the Institute of Medicine (IOM), according to a new study by researchers from Hospital for Special Surgery in New York. The study will be presented at the Endocrine Society's Annual Meeting in Boston, June 4-7.

7 Jun 2011

Women with higher leptin levels have fewer symptoms of depression

Women who have higher levels of the appetite-controlling hormone leptin have fewer symptoms of depression, and this apparent inverse relationship is not related to body mass index (BMI), a new study finds.

7 Jun 2011

Exelixis reports encouraging interim data from cabozantinib phase 2 trial for metastatic CRPC

Exelixis, Inc. today reported updated interim data from the fully enrolled cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with cabozantinib (XL184) in a phase 2 adaptive randomized discontinuation trial (RDT).

7 Jun 2011

Female cancer survivors benefit from natural nutritional supplement

A natural nutritional supplement, marketed for the last decade as a sexual aid, has been shown to significantly improve overall quality of life for female cancer survivors, according to researchers at Wake Forest Baptist Medical Center.

7 Jun 2011

Symphogen's Sym004 Phase 1 trial data on advanced solid tumors presented at ASCO 2011

Symphogen announced today preliminary primary endpoint data on 12 of 20 patients enrolled in the first Phase 1 clinical trial with their lead cancer compound, Sym004.

7 Jun 2011

Women with low bone density more likely to benefit from bisphosphonate drug

Women with low bone density are seven times more likely to benefit from a bisphosphonate drug when their vitamin D blood levels are above recent recommendations from the Institute of Medicine (IOM) as adequate for bone health.

7 Jun 2011

David Cameron’s NHS promises

Prime Minister David Cameron gives out “five guarantees” regarding the future of the NHS in England amid details of when changes to planned reforms will be considered. He promised that NHS will remain free at the point of use, care will be improved and budgets will rise and waiting times will be “kept low”.

7 Jun 2011

Jindal's Medicaid plan questioned; Wash. lawmakers enact fee on nursing homes to increase federal match

Calling it a "dubious privatization venture," a Baton Rouge good-government group last week questioned Gov. Bobby Jindal's plan to turn over large chunks of the state Medicaid program to private insurers and praised the Louisiana House of Representatives for trying to slow the process.

7 Jun 2011

Manhattan acquires Senior Scientific

In a move to accelerate applications of a novel cancer detection and treatment technology, Manhattan Scientifics today announced that it has acquired all of Senior Scientific, LLC and its affiliate Scientific Nanomedicine Inc.

7 Jun 2011

Brainlab enters into definitive agreement to acquire Voyant Health

Brainlab announced today that it has entered into a definitive agreement to acquire Voyant Health.

7 Jun 2011

"Best Doctors" survey finds NY Presbyterian has the most top doctors in metro area

For the eleventh straight year, NewYork-Presbyterian has more physicians listed in New York Magazine's "Best Doctors" survey than any other hospital. The magazine lists 191 NewYork-Presbyterian physicians representing 17 percent of the 1,144 New York City–area doctors listed. The "Best Doctors" issue is on newsstands today. For the full list of physicians and ranking methodology, visit nymag.com/bestdoctors.

6 Jun 2011

Onconova to initiate ESTYBON Phase II/III study in pancreatic cancer

Onconova Therapeutics, Inc. announced two advances in the clinical development of ESTYBON (rigosertib, ON 01910.Na) in presentations at the annual meeting of the American Society of Clinical Oncology (ASCO), June 3-7, 2011, in Chicago, Illinois.

6 Jun 2011

Life Technologies develops qPCR-based accurate test to detect E. coli

Life Technologies Corporation today announced that it has developed a custom test (assay) to accurately detect the E. coli bacterium that has killed at least 22 people and affected more than 2,100 worldwide, including four new cases reported in the United States. Shipments of the TaqMan® E. coli 0104 Detection Kit to test foods thought to be associated with the outbreak are now in Europe.

6 Jun 2011

Merge Healthcare, Ophthalmic Imaging Systems enter definitive merger agreement

Merge Healthcare, a leading provider of healthcare enterprise imaging and interoperability solutions, and Ophthalmic Imaging Systems, a leading provider of digital imaging and informatics solutions for ophthalmology and other medical specialties, today announced the signing of a definitive merger agreement pursuant to which Merge Healthcare will acquire OIS.

6 Jun 2011

EUS-guided GI biopsies with Cook Medical's new, large-core biopsy needle overcomes limitations

Results from a multicenter European study suggest that a new, large-core biopsy needle designed for use with an endoscopic ultrasound (EUS) scope may help to overcome limitations of current EUS methods for biopsies of lesions in the gastrointestinal (GI) tract and surrounding tissue.

6 Jun 2011

Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million

Ganeden Biotech announced the sale of its leading Sustenex® and Digestive Advantage® brands of probiotic dietary supplements to Schiff Nutrition International, Inc. for $40 million in cash. Ganeden will also receive royalties on Schiff products containing GanedenBC30™.

6 Jun 2011

Hospital News and Research

Race impacts risk of heart disease after gestational diabetes

Higher than IOM recommended Vitamin D levels required for optimizing osteoporosis, low BMD therapy

Women with higher leptin levels have fewer symptoms of depression

Exelixis reports encouraging interim data from cabozantinib phase 2 trial for metastatic CRPC

Female cancer survivors benefit from natural nutritional supplement

Symphogen's Sym004 Phase 1 trial data on advanced solid tumors presented at ASCO 2011

Women with low bone density more likely to benefit from bisphosphonate drug

David Cameron’s NHS promises

Jindal's Medicaid plan questioned; Wash. lawmakers enact fee on nursing homes to increase federal match

Manhattan acquires Senior Scientific

Brainlab enters into definitive agreement to acquire Voyant Health

"Best Doctors" survey finds NY Presbyterian has the most top doctors in metro area

Onconova to initiate ESTYBON Phase II/III study in pancreatic cancer

Life Technologies develops qPCR-based accurate test to detect E. coli

Merge Healthcare, Ophthalmic Imaging Systems enter definitive merger agreement

EUS-guided GI biopsies with Cook Medical's new, large-core biopsy needle overcomes limitations

Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million

Enrollment complete in Adolor's ADL5945 Phase 2 clinical study in opioid-induced constipation

Ohio's Adena Health System chooses eClinicalWorks EHR solution for physicians

First Edition: June 6, 2011

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News